STEM Stem Q4 2025 EPS beats consensus forecasts by 24 percent shares gain 115 percent in daily trading Sangamo Therapeutics SGMO Stock Momentum Analysis Sangamo Therapeutics posts 797 downside EPS miss TACHW Titan management outlines key strategic priority of pursuing highgrowth tech acquisition targets this year